Nan Fung Group Holdings Ltd — 13F Holdings

2026 Q3  ·  30 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Nan Fung Group Holdings Ltd maintained a portfolio of 30 distinct positions. The most significant new addition was OBSIDIAN THERAPEUTICS INC, now representing 8.43% of the total fund value. They heavily accumulated shares in PROCORE TECHNOLOGIES INC, increasing the position by 66.7%. The fund also reduced its exposure to RECURSION PHARMACEUTICALS IN by 69.5%.
Position History hover any row below to update
Loading…
Nan Fung Group Holdings Ltd Hong Kong Family Office / Asset Manager AUM $150M
PCA Score Concentration Risk
Risk ENB
Total Positions
30
Quarter
2026 Q3
Top Holding
LBRX (16.2%)
Top 10 Concentration
75.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-30 of 30

Nan Fung Group Holdings Ltd Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
LBRX
LB PHARMACEUTIC...
Healthcare 16.17% 15.57% #1 1
Prev: #2
7.0
—
no change no change
P
S
630,657 $24,204,616
$20.44 +97.2%
$38.38 +5.0%
2025 Q3 13F Filing 2026-09-30 2026-11-13
MPLT
MAPLIGHT THERAP...
Healthcare 15.66% 26.47% #2 1
Prev: #1
8.5
—
1,329,075 136.8%
P
S
2,300,328 $23,440,342 2025 Q4 13F Filing 2026-09-30 2026-11-13
OBX
OBSIDIAN THERAP...
Healthcare 8.43% — #3
Prev: #—
7.9
—
918,765 —
NEW
918,765 $12,614,643 2026 Q3 13F Filing 2026-09-30 2026-11-13
CYBN
CYBIN INC
Unknown 8.11% 4.96% #4
Prev: #4
4.7
—
no change no change
P
S
987,222 $12,132,958 2025 Q4 13F Filing 2026-09-30 2026-11-13
EVMN
EVOMMUNE INC
Healthcare 7.95% 14.56% #5 2
Prev: #3
4.7
—
no change no change
P
S
1,441,032 $11,902,924 2025 Q4 13F Filing 2026-09-30 2026-11-13
NUVB
NUVATION BIO IN...
Healthcare 4.97% — #6
Prev: #—
5.5
—
1,327,224 —
NEW
1,327,224 $7,432,454 2026 Q3 13F Filing 2026-09-30 2026-11-13
INCY
INCYTE CORP
Healthcare 4.36% 4.63% #7 2
Prev: #5
2.7
—
no change no change
P
S
53,742 $6,521,592 2021 Q4 13F Filing 2026-09-30 2026-11-13
ONC
BEONE MEDICINES...
Healthcare 3.84% 3.41% #8 1
Prev: #7
2.5
—
no change no change
P
S
15,722 $5,753,309 2021 Q4 13F Filing 2026-09-30 2026-11-13
RYTM
RHYTHM PHARMACE...
Healthcare 3.12% 4.15% #9 3
Prev: #6
2.2
—
no change no change
P
S
49,120 $4,676,961 2022 Q4 13F Filing 2026-09-30 2026-11-13
PCOR
PROCORE TECHNOL...
Technology 3.07% 1.65% #10 7
Prev: #17
4.2
—
35,533 66.7%
P
S
88,832 $4,594,391 2025 Q4 13F Filing 2026-09-30 2026-11-13
NAMS
NEWAMSTERDAM PH...
Healthcare 2.68% — #11
Prev: #—
4.6
—
164,986 —
NEW
164,986 $4,012,460 2026 Q3 13F Filing 2026-09-30 2026-11-13
RVMD
REVOLUTION MEDI...
Healthcare 2.64% 2.74% #12 2
Prev: #10
2.1
—
no change no change
P
S
19,253 $3,951,871 2024 Q1 13F Filing 2026-09-30 2026-11-13
KYMR
KYMERA THERAPEU...
Healthcare 2.31% 2.69% #13 2
Prev: #11
1.9
—
no change no change
P
S
30,875 $3,451,516 2021 Q4 13F Filing 2026-09-30 2026-11-13
ASND
ASCENDIS PHARMA...
Healthcare 2.07% 2.76% #14 5
Prev: #9
1.8
—
no change no change
P
S
13,600 $3,098,488 2021 Q4 13F Filing 2026-09-30 2026-11-13
MDGL
MADRIGAL PHARMA...
Healthcare 1.91% 2.32% #15 3
Prev: #12
1.8
—
no change no change
P
S
5,672 $2,858,461 2022 Q4 13F Filing 2026-09-30 2026-11-13
OCS
OCULIS HOLDING ...
Healthcare 1.88% 3.17% #16 8
Prev: #8
1.8
—
no change no change
P
S
300,565 $2,807,277 2023 Q1 13F Filing 2026-09-30 2026-11-13
ARGX
ARGENX SE
Healthcare 1.79% 1.98% #17 2
Prev: #15
1.7
—
no change no change
P
S
2,800 $2,684,948 2021 Q4 13F Filing 2026-09-30 2026-11-13
N/A
TCGX ACQUISITIO...
Unknown 1.67% — #18
Prev: #—
4.2
—
200,000 —
NEW
200,000 $2,502,000 — 13F Filing 2026-09-30 2026-11-13
CELC
CELCUITY INC
Healthcare 1.50% 2.25% #19 6
Prev: #13
1.6
—
no change no change
P
S
28,300 $2,250,416 2026 Q1 13F Filing 2026-09-30 2026-11-13
ACAD
ACADIA PHARMACE...
Healthcare 1.39% 1.98% #20 6
Prev: #14
1.6
—
no change no change
P
S
102,984 $2,075,128 2021 Q4 13F Filing 2026-09-30 2026-11-13
BRVE
BRAVEHEART BIO ...
Healthcare 1.10% — #21
Prev: #—
3.9
—
81,376 —
NEW
81,376 $1,643,795 2026 Q3 13F Filing 2026-09-30 2026-11-13
HRMY
HARMONY BIOSCIE...
Healthcare 0.71% 0.75% #22 4
Prev: #18
1.3
—
no change no change
P
S
27,049 $1,061,944 2021 Q2 13F Filing 2026-09-30 2026-11-13
ETHA
ISHARES ETHEREU...
ETF 0.68% 0.46% #23 3
Prev: #20
1.3
—
no change no change
P
S
50,549 $1,017,046 2025 Q3 13F Filing 2026-09-30 2026-11-13
IBIT
ISHARES BITCOIN...
Bond/Debt 0.51% 0.40% #24 3
Prev: #21
1.2
—
no change no change
P
S
15,968 $755,925 2025 Q3 13F Filing 2026-09-30 2026-11-13
INSM
INSMED INC
Healthcare 0.50% 0.53% #25 6
Prev: #19
1.2
—
no change no change
P
S
6,580 $751,041 2026 Q1 13F Filing 2026-09-30 2026-11-13
RXRX
RECURSION PHARM...
Healthcare 0.50% 1.66% #26 10
Prev: #16
0.2
—
-413,656 -69.5%
P
S
181,631 $750,136 2024 Q4 13F Filing 2026-09-30 2026-11-13
RANI
RANI THERAPEUTI...
Healthcare 0.26% 0.29% #27 4
Prev: #23
1.1
—
no change no change
P
S
493,584 $390,425 2021 Q3 13F Filing 2026-09-30 2026-11-13
TRDA
ENTRADA THERAPE...
Healthcare 0.21% 0.27% #28 4
Prev: #24
1.1
—
no change no change
P
S
49,082 $311,671 2022 Q1 13F Filing 2026-09-30 2026-11-13
BOLT
BOLT BIOTHERAPE...
Healthcare 0.01% 0.01% #29 4
Prev: #25
1.0
—
no change no change
P
S
5,000 $18,400 2021 Q2 13F Filing 2026-09-30 2026-11-13
CHYM
CHIME FINL INC
Technology 0.00% 0.33%
Sold All 😨
(Was: #22)
0.0
—
-21,075 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-13
Showing 1-30 of 30 holdings

Unlock Full Nan Fung Group Holdings Ltd Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →